Arkadios Wealth Advisors’s Zimmer Biomet ZBH Stock Holding History

Arkadios Wealth Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206K	Buy	2,390 +86	+4%	+$7.54K	﹤0.01%	1620
2026 Q1	$208K	Buy	2,304 +24	+1%	+$2.2K	﹤0.01%	1551
2025 Q4	$205K	Buy	+2,280	New	+$216K	﹤0.01%	1442
2021 Q4	–	Sell	-149	Closed	-$21K	–	1822
2021 Q3	$21K	Sell	149 -58	-28%	-$8.53K	﹤0.01%	1205
2021 Q2	$32K	Buy	207 +76	+58%	+$12.3K	﹤0.01%	1104
2021 Q1	$20K	Buy	131 +27	+26%	+$4.18K	﹤0.01%	973
2020 Q4	$15K	Buy	+104	New	+$14.7K	﹤0.01%	853

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arkadios Wealth Advisors's ZBH Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its Zimmer Biomet (ZBH) stake by 3.7% in Q2 2026, buying an estimated $7.54K and bringing the position to 2,390 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #1620.

Arkadios Wealth Advisors first reported a position in ZBH in Q4 2020 and has held it in 7 quarters since. The position peaked at $208K in Q1 2026. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Arkadios Wealth Advisors held 2,390 shares of Zimmer Biomet worth $206K as of Q2 2026.
Arkadios Wealth Advisors bought 86 Zimmer Biomet shares in Q2 2026, an estimated $7.54K.
Zimmer Biomet made up ﹤0.01% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #1620 holding.
Arkadios Wealth Advisors first reported a position in Zimmer Biomet in Q4 2020 and has held it in 7 quarters since.
Arkadios Wealth Advisors's Zimmer Biomet position peaked at $208K in Q1 2026.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.